160 related articles for article (PubMed ID: 2458825)
1. Histologic markers in primary and metastatic tumors of the liver.
Ganjei P; Nadji M; Albores-Saavedra J; Morales AR
Cancer; 1988 Nov; 62(9):1994-8. PubMed ID: 2458825
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
Ferrandez-Izquierdo A; Llombart-Bosch A
Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Chu PG; Ishizawa S; Wu E; Weiss LM
Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
[TBL] [Abstract][Full Text] [Related]
4. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
Brumm C; Schulze C; Charels K; Morohoshi T; Klöppel G
Histopathology; 1989 May; 14(5):503-13. PubMed ID: 2472345
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical evaluation of liver fine-needle aspirations.
Bedrossian CW; Davila RM; Merenda G
Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin.
Martín de las Mulas J; Gómez-Villamandos JC; Pérez J; Mozos E; Estrado M; Méndez A
Res Vet Sci; 1995 Sep; 59(2):124-7. PubMed ID: 8525100
[TBL] [Abstract][Full Text] [Related]
8. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
[TBL] [Abstract][Full Text] [Related]
10. Tumour markers in diagnosis and management.
Warnes TW; Smith A
Baillieres Clin Gastroenterol; 1987 Jan; 1(1):63-89. PubMed ID: 2437983
[TBL] [Abstract][Full Text] [Related]
11. A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma.
Yano H; Kojiro M; Nakashima T
In Vitro Cell Dev Biol; 1986 Nov; 22(11):637-46. PubMed ID: 2430933
[TBL] [Abstract][Full Text] [Related]
12. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Tsuji M; Kashihara T; Terada N; Mori H
Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
[TBL] [Abstract][Full Text] [Related]
14. Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
Fucich LF; Cheles MK; Thung SN; Gerber MA; Marrogi AJ
Arch Pathol Lab Med; 1994 Sep; 118(9):927-30. PubMed ID: 7521638
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA.
Oliveira AM; Erickson LA; Burgart LJ; Lloyd RV
Am J Surg Pathol; 2000 Feb; 24(2):177-82. PubMed ID: 10680884
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of alpha-fetoprotein, carcinoembryonic antigen, and ferritin in formalin-paraffin sections from hepatocellular carcinoma.
Imoto M; Nishimura D; Fukuda Y; Sugiyama K; Kumada T; Nakano S
Am J Gastroenterol; 1985 Nov; 80(11):902-6. PubMed ID: 2413756
[TBL] [Abstract][Full Text] [Related]
17. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
Fu X; Tan L; Liu S; Li H; Chen L; Qin J; Wu M; Wang H
J Cancer Res Clin Oncol; 2004 Sep; 130(9):514-20. PubMed ID: 15221469
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of tumour marker proteins in the diagnosis of primary hepatocellular carcinoma.
Oon CJ; Yo SL; Chio LF; Chua D; Tan YO
Ann Acad Med Singap; 1980 Apr; 9(2):228-33. PubMed ID: 6158907
[TBL] [Abstract][Full Text] [Related]
19. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Goodman ZD; Ishak KG; Langloss JM; Sesterhenn IA; Rabin L
Cancer; 1985 Jan; 55(1):124-35. PubMed ID: 2578078
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Bell H
Scand J Gastroenterol; 1982 Oct; 17(7):897-903. PubMed ID: 6186010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
